ICU Trials by ClinCalc vs myAir™ by Resmed
ICU Trials by ClinCalc
ClinCalc LLC
Google Play
$588/mo
~$7.1K/yr · 10K installs
VS
myAir™ by Resmed
Resmed
Google Play
$0/mo
~$0/yr · 4.2M installs
Revenue winner
ICU Trials by ClinCalc wins
+58800% vs other
Installs winner
myAir™ by Resmed wins
+42723% vs other
MAU winner
myAir™ by Resmed wins
+24568% vs other
Rating winner
ICU Trials by ClinCalc wins
+7% vs other
Why ICU Trials by ClinCalc is winning
Top 2 reasons - backed by the public App Store / Play Store numbers.
- ICU Trials by ClinCalc earns roughly 588× more per month than myAir™ by Resmed - $588 vs $0.
- Better app store reviews. ICU Trials by ClinCalc sits at 4.59★ vs 4.28★ - store algorithms reward higher-rated apps with more impressions.
→ Find more apps with this revenue gap · Full ICU Trials by ClinCalc report
Side-by-side metrics
Bars scale to whichever app is bigger on that row. Green = winner.
ICU Trials by ClinCalc
vs
myAir™ by Resmed
Monthly revenue (est.)?
$588
◀
$0
Annual revenue (est.)
$7.1K
◀
$0
Lifetime installs (est.)
10K
▶
4.2M
Monthly active users (est.)?
2K
▶
526K
App Store rating
4.59★
◀
4.28★
Total ratings
224
▶
36K
US grossing rank
-
=
-
Cheapest monthly sub
No sub
=
No sub
IAP tiers detected
0 tiers
=
0 tiers
- Category
- Medical
- Price
- USD4.99
- Released
- Jun 9, 2012
- Last updated
- Jul 10, 2024
- File size
- -
- Content rating
- Everyone
- Version
- 3.5
- Languages
- -
- Category
- Medical
- Price
- Free
- Released
- Apr 17, 2018
- Last updated
- Apr 10, 2026
- File size
- -
- Content rating
- Everyone
- Version
- VARY
- Languages
- -
ICU Trials by ClinCalc trajectory
myAir™ by Resmed trajectory
FAQ
Which makes more money, ICU Trials by ClinCalc or myAir™ by Resmed? v
ICU Trials by ClinCalc earns about $588 per month, while myAir™ by Resmed earns about $0. That is a ∞× revenue gap (~$588 more per month for ICU Trials by ClinCalc). Annual revenue: ICU Trials by ClinCalc ≈ $7.1K/year, myAir™ by Resmed ≈ $0/year. Estimates are derived from public Google Play signals - grossing rank, scraped IAP tiers, ratings and category benchmarks.
Which has more downloads, ICU Trials by ClinCalc or myAir™ by Resmed? v
myAir™ by Resmed leads with about 4.2M estimated downloads vs 10K for ICU Trials by ClinCalc - a 428.2× gap. ICU Trials by ClinCalc reports 5,000+ installs on Google Play. myAir™ by Resmed reports 1,000,000+ installs on Google Play.
Are ICU Trials by ClinCalc and myAir™ by Resmed in the same Google Play category and competing for the same money? v
Yes - both apps sit in the Medical category, which means they compete directly for the same paying users and category-level wallet share. Direct competitors, head-to-head.
Do ICU Trials by ClinCalc and myAir™ by Resmed have in-app purchases? v
ICU Trials by ClinCalc does not appear to offer in-app purchases on its public listing. myAir™ by Resmed does not appear to offer in-app purchases. Monetization model: ICU Trials by ClinCalc runs "Paid app ($4.99)", myAir™ by Resmed runs "No App Store revenue (monetizes off-store)".
Which has better ratings, ICU Trials by ClinCalc or myAir™ by Resmed? v
ICU Trials by ClinCalc edges ahead with ★ 4.6 vs ★ 4.3 (gap of 0.3 stars). Rating volume: ICU Trials by ClinCalc 16 ratings, myAir™ by Resmed 11K ratings. Higher rating volume = stronger ASO signal even when star averages are close.
How accurate are these ICU Trials by ClinCalc vs myAir™ by Resmed revenue estimates? v
Directional - typically within 2-3× of actual money earned for popular apps. The $588 for ICU Trials by ClinCalc and $0 for myAir™ by Resmed are derived from Google Play grossing rank, scraped IAP tiers, ratings volume and category benchmarks (Medical) - net of the 15-30% Apple/Google store cut. Real revenue depends on country mix, retention, refunds and ad fill rate, none of which Apple or Google publish.
How do I compare ICU Trials by ClinCalc or myAir™ by Resmed to a different Google Play app? v
Use the search box at the bottom of this page or paste any two Google Play links into the homepage tool. We auto-generate a permanent comparison URL with revenue, downloads, IAP tiers, subscription pricing and grossing rank for both apps.